Obstet Gynecol Sci.
2015 Jul;58(4):331-332. 10.5468/ogs.2015.58.4.331.
Comment on: Endometrial cancer occurrence five years after breast cancer in BRCA2 mutation patient
- Affiliations
-
- 1Comprehensive Gynecologic Cancer Center, Department of Obstetrics and Gynecology, CHA Bundang Medical Center, CHA University, Seongnam, Korea. oursk79@cha.ac.kr
- KMID: 2314057
- DOI: http://doi.org/10.5468/ogs.2015.58.4.331
Abstract
- No abstract available.
Reference
-
1. Oh SE, Kim SH, Kim MS, Kim MK. Endometrial cancer occurence five years after breast cancer in BRCA2 mutation patient. Obstet Gynecol Sci. 2015; 58:175–178.2. Radice P, De Summa S, Caleca L, Tommasi S. Unclassified variants in BRCA genes: guidelines for interpretation. Ann Oncol. 2011; 22:Suppl 1. i18–i23.3. National Human Genome Research Institute. National Institutes of Health. Breast Cancer Information Core: an open access on-line breast cancer mutation data base [Internet]. Bethesda (MD): National Human Genome Research Institute;2015. cited 2015 May 29. Available from: http://research.nhgri.nih.gov/projects/bic/.4. Levine DA, Lin O, Barakat RR, Robson ME, McDermott D, Cohen L, et al. Risk of endometrial carcinoma associated with BRCA mutation. Gynecol Oncol. 2001; 80:395–398.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Endometrial cancer occurence five years after breast cancer in BRCA2 mutation patient
- Frequency of BRCA1 and BRCA2 Germline Mutations Detected by Protein Truncation Test and Cumulative Risks of Breast and Ovarian Cancer among Mutation Carriers in Japanese Breast Cancer Families
- Bilateral Triple-Negative Invasive Breast Cancer with a BRCA2 Mutation, and Glioblastoma: A Case Report and Literature Review
- Novel Germline Mutations of BRCA1 and BRCA2 in Korean Familial Breast Cancer Patients
- The Novel Pathogenic Mutation c.849dupT in BRCA2 Contributes to the Nonsense-Mediated mRNA Decay of BRCA2 in Familial Breast Cancer
